Marilyn Metcalf

Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action

Anton Hoos, James W. Anderson, Marc Boutin et al. · Therapeutic Innovation & Regulatory Science · 2015 · 187 citations · Full text

Recommendations for benefit–risk assessment methodologies and visual representations

Diana Hughes, Ed Waddingham, Shahrul Mt‐Isa et al. · Pharmacoepidemiology and Drug Safety · 2016 · 65 citations · Full text

Living with tuberculosis: a qualitative study of patients’ experiences with disease and treatment

Juliet Addo, Dave Pearce, Marilyn Metcalf et al. · BMC Public Health · 2022 · 45 citations · Full text

Patient Engagement at a Tipping Point—The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, “Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products”

Meredith Y. Smith, Tarek A. Hammad, Marilyn Metcalf et al. · Therapeutic Innovation & Regulatory Science · 2016 · 35 citations · Full text

Benefit–risk assessment in a post‐market setting: a case study integrating real‐life experience into benefit–risk methodology

Christine E. Hallgreen, Hendrika A. van den Ham, Shahrul Mt‐Isa et al. · Pharmacoepidemiology and Drug Safety · 2014 · 21 citations